Associate Professor Liao Ping serves as Principal Investigator and Clinician Scientist at the National Neuroscience Institute, specialising in ion channels and neurological diseases. His research focuses on understanding the aberrant ion channel functions in the development of neurological diseases, in particular cerebrovascular diseases.

A/Prof Liao Ping has developed a series of therapeutic antibodies targeting TRPM4 channel. These antibodies have the potential to manage stroke, vascular dementia, head injury and others with hypoxia/ischemia insult.

• M.B.B.S., M. Surgery (Neurosurgery), West China University of Medical Sciences (Sichuan, P.R. China), 1989 – 1996
• ​Ph.D. Division of Neurosurgery, Department of Surgery, National University of Singapore, 1997 - 2002

• Clinician Scientist and Principal Investigator, National Neuroscience Institute
• Associate Professor, Neuroscience Academic Clinical Programme
• Joint Associate Professor, Duke-NUS Medical School
• Joint Associate Professor, Singapore Institute of Technology

• PhD Scholarship, National University of Singapore, 1997 - 2001
• Swee-Liew Wadsworth Research Gold Award, 2014

• Ion channels and cerebrovascular diseases
• Novel antibody therapies for neurological disorders

• Wei S, Poore CP, Verma RK, Low SW, Chen B, Fan H, Liao P*. Development and in vitro characterization of humanized antibodies for blocking human TRPM4 channel. Sci Rep. 2025 Jun 5;15(1):19769.
• Poore CP, Yang J, Wei S, Fhu CK, Bichler Z, Wang J, Soong TW, Liao P*. Enhanced isradipine sensitivity in vascular smooth muscle cells due to hypoxia-induced Cav1.2 splicing and RbFox1/Fox2 downregulation. FEBS J. 2024 Oct;291(19):4265-4285.
• Poore CP, Hazalin NAMN, Wei S, Low SW, Chen B, Nilius B, Hassan Z, Liao P*. TRPM4 blocking antibody reduces neuronal excitotoxicity by specifically inhibiting glutamate-induced calcium influx under chronic hypoxia. Neurobiol Dis. 2024 Feb;191:106408
• Wei S, Chen B, Low SW, Poore CP, Gao Y, Nilius B, Liao P*. SLC26A11 Inhibition Reduces Oncotic Neuronal Death and Attenuates Stroke Reperfusion Injury. Mol Neurobiol. 2023 Oct;60(10):5931-5943.
• Chen B, Wei S, Low SW, Poore CP, Lee AT, Nilius B, Liao P*. TRPM4 Blocking Antibody Protects Cerebral Vasculature in Delayed Stroke Reperfusion. Biomedicines. 2023 May 19;11(5):1480.
• For Full List of Publications: Liao Ping-Google Scholar